Rivastigmine (Exelon) in the treatment of senile dementia of the Alzheimer type (SDAT) /
Stein, Ken,1963-
NHS Executive.South and West.Research and Development Directorate.
Wessex Institute for Health Research and Development.Development & Evaluation Committee.
Bristol : NHS Executive South & West R&D Directorate,
1998.
Includes bibliography.